Skip links

GSS EU Science Funding Gateway

2D materials-based devices and systems for biomedical applications (RIA)

Summary

Cluster 4 promotes investments that will shape competitive and trusted technologies for a European industry enabling production and consumption to respect the planet’s boundaries and maximising the benefits for all parts of society in the variety of social, economic and territorial contexts in Europe. This will build a competitive, digital, low-carbon and circular industry, ensure sustainable supply of raw materials, develop advanced materials and provide the basis for advances and innovation in global challenges to society.

Programme Name

Horizon Europe (2021-2027)

Programme Description

Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.

Programme Details

Call

2D materials-based devices and systems for biomedical applications (RIA)

Detailed Call Description

Proposals should build on the multi-functionality allowed by 2DMs and demonstrate the advantages of combining e.g. biocompatibility, chemical stability, (bio-)sensing and actuating, and integration with flexible electronic technologies, in addition to versatile surface chemistry (for interface with biology) to allow continuous health monitoring and built-in pharmacological interventions.

The proposals should bring together multidisciplinary teams including engineers, material scientists, pharmacologists, biologists, clinicians, patients, and ethics experts.

Potential application areas include:

  • engineering & bioengineering of biochemical or bioelectronic diagnostics or therapeutic devices and platforms
  • sensors for digital health
  • electronics for brain-computer interfaces, taking advantage of flexible devices
  • medical imaging in combination with implantable devices (e.g. MRI)
  • graphene for drug delivery of therapeutics (e.g. for neurological disorders).

The safety aspects of the proposed technologies should be given proper consideration.

Financing percentage by EU or other bodies / Level of Subsidy or Loan

100%

EU contribution per project:  €6,00 million

Programme Category
EU Competitive Programmes
Total Budget
€6,00 million
Thematic Categories
  • Health
  • Industry
  • Research, Technological Development and Innovation
Eligibility for Participation
  • Large Enterprises
  • Other Beneficiaries
  • Private Bodies
  • Researchers/Research Centers/Institutions
  • State-owned Enterprises
Call Opening Date
16/06/2022
Call Closing Date
16/11/2022
National Contact Point(s)

Research and Innovation Foundation

29a Andrea Michalakopoulou Street, 1075 Nicosia
T.Th. 23422, 1683 Nicosia
+357 22205000
Email: support@research.org.cy

Dr Angelos Ntantos
Scientific Officer
Telephone: 35722205033
Email: antantos@research.org.cy

Dr Ioannis Theodorou

Scientific Officer
Telephone: 35722205038
Email: itheodorou@research.org.cy

(Publish Date: 14/02/2022-for internal use only)

EU Contact Point

Εuropean Commission, Directorate-General for Research and Innovation

https://ec.europa.eu/info/departments/research-and-innovation_en#contact

Website
Funding&Tenders HE Main Work Programme 2021–2022 – Digital, Industry and Space p.294
This website uses cookies to improve your web experience.
Home
Account
Cart
Search
Explore
Drag